1 1 1.09 0.87 – 1 0.9 0.99 0.79 – 1 0.8 0.89 0.7 – 1 0.7 0.79 0.62 – 1 0.6 0.69 0.54 – 1 0.5 0.59 0.45 – 1 0.4 0.49 0.37 – 72 hours 1 1.5 1.59 1.9 – Expected Number of Volume of Blincyto vials Dose Cassette Duration BSA (m2) Reconstituted required* BLINCYTO 1 1.4 1.49 1.8 – 1 1.3 1.39 1.7 – 1 1.2 1.29 1.6 – 1 1.1 1.19 1.4 – 1 1 1.09 1.3 – 1 0.9 0.99 1.2 – 1 0.8 0.89 1.1 – 1 0.7 0.79 0.93 – 1 0.6 0.69 0.81 – 1 0.5 0.59 0.68 – 1 0.4 0.49 0.56 – 1 1.5 1.59 2.6 – 96 hours 1 1.4 1.49 2.4 –
1 1 – 1.09 0.87 1 0.9 – 0.99 0.79 1 0.8 – 0.89 0.7 1 0.7 – 0.79 0.62 1 0.6 – 0.69 0.54 1 0.5 – 0.59 0.45 1 0.4 – 0.49 0.37 72 hours 1 1.5 – 1.59 1.9 Dose Cassette Duration Expected Number of Blincyto vials required* BSA (m2) Volume of Reconstituted BLINCYTO 1 1.4 – 1.49 1.8 1 1.3 – 1.39 1.7 1 1.2 – 1.29 1.6 1 1.1 – 1.19 1.4 1 1 – 1.09 1.3 1 0.9 – 0.99 1.2 1 0.8 – 0.89 1.1 1 0.7 – 0.79 0.93 1 0.6 – 0.69 0.81 1 0.5 – 0.59 0.68 1 0.4 – 0.49 0.56 96 hours 1 1.5 – 1.59 2.6 1 1.4 – 1.49 2.4
auspar-blinatumomab-180205-pi.docx